News

From 1 February 2016 companies will no longer be required to submit type IA variations in relation to the Qualified Person Responsible for Pharmacovigilance Information for marketing authorisation holders The State...

From 1 February 2016 companies will no longer be required to submit type IA variations in relation to the Qualified Person Responsible for Pharmacovigilance Information for marketing authorisation holders The State...

The ISO recertification audit at the State Agency of Medicines has been successfully completed At the end of 2015 the integrated management system of the State Agency of Medicines (SAM) has been recertified as in...

Amendments to the paid service price list of the State Agency of Medicines Please note that the 22 December 2015 Cabinet of Ministers Regulation No. “Amendments to the 17 September 2013 Cabinet of Ministers Regulation No...

Compulsory use of electronic application forms (eAF) From 1 January 2016 the use of electronic application forms (eAF) for MRP/DCP and national procedures (initial MAs, renewals, variations) will be mandatory within...

Compulsory use of electronic application forms (eAF) From 1 January 2016 the use of electronic application forms (eAF) for MRP/DCP and national procedures (initial MAs, renewals, variations) will be mandatory within...

Common regulation of medical devices in Europe and patient safety are the priorities Svens Henkuzens, the Director of the State Agency of Medicines, and Daiga Lagzdiņa, the Head of the Medical Devices Evaluation...

Common regulation of medical devices in Europe and patient safety are the priorities Svens Henkuzens, the Director of the State Agency of Medicines, and Daiga Lagzdiņa, the Head of the Medical Devices Evaluation...

New Deputy Director of the State Agency of Medicines Jānis Zvejnieks The State Agency of Medicines of Latvia (SAM) informs that Jānis Zvejnieks has been appointed as the Deputy Director of SAM. Since September 2013 J...